Dr Reddy’s launch fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets

They are available in a 20 count blister

Dr Reddy’s Laboratories has launched its over-the-counter (OTC) fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg/120 mg, a bioequivalent generic version of Allegra-D 12 Hour Allergy & Congestion, in the US market . Dr Reddy’s ANDA is approved by the United States Food & Drug Administration (USFDA).

The Allegra-D12 Hour brand has US sales of approximately $49.8 million for the latest 52 weeks ending October 6, 2014 for Total US Multi Outlet according to IRI.

Dr Reddy’s fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg/120 mg are available in a 20 count blister.

EP News Bureau – Mumbai